A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-ß1a using RebiSmart™-the FUTURE study.
Neurol Sci
; 38(11): 1999-2005, 2017 Nov.
Article
in En
| MEDLINE
| ID: mdl-28831635
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Adjuvants, Immunologic
/
Multiple Sclerosis, Relapsing-Remitting
/
Interferon beta-1a
Type of study:
Clinical_trials
/
Observational_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Language:
En
Journal:
Neurol Sci
Journal subject:
NEUROLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Italy
Country of publication:
Italy